Synopsys is Hot Again But a Pattern Has Emerged
Synopsys has beaten earnings estimates three times this year, yet shareholders have walked away from each report with less than they started. A chart pattern that keeps repeating raises a pointed question about whether strong fundamentals can ever outrun the…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Synopsys (NASDAQ:SNPS | SNPS Price Prediction) trades at $488.47. The chip-design software leader is rallying again, and its 2026 chart has already shown three distinct peaks. Each of those peaks faded.
Synopsys leads electronic design automation (EDA), the software chipmakers use to design and verify semiconductors. It also licenses silicon IP. The roughly $35B Ansys acquisition turned it into a silicon-to-systems engineering provider. Shares rose 16.97% in a week, and Barron’s named it the top stock in the Nasdaq 100 during one recent session.
Three Beat-and-Raise Quarters Power the AI Design Story
Fiscal Q3 revenue reached $2.48B, up 42.4% YoY. Non-GAAP EPS came in at $3.91 against a $3.67 consensus. Management raised full-year guidance for the second straight quarter, to non-GAAP EPS of $15.04 to $15.10. Design IP returned to growth, rising about 11% to $474 million. EDA growth is expected to speed up to double digits.
New products give the story more room to run. Multiphysics Fusion, the first joint Synopsys-Ansys product, delivered up to 10x faster design closure for early customers and should start adding to EDA growth in 2027. Synopsys is also pursuing license-plus-royalty deals with AI customers (the broader AI expansion extends well past the chipmakers themselves, something we covered across power, cooling, and infrastructure suppliers in a free report here). At a forward P/E of 23, investors are paying that multiple for ~$2.6B in guided free cash flow.
Every Earnings Beat This Year Ended in a Selloff
On average, the stock fell 2.35% the day after an earnings beat. Thirty days after the Q1, Q2, and Q3 reports, shares were down 10.06%, 7.19%, and 10.71%. Strong results have repeatedly failed to hold the stock up.
Debt still remains near $10 billion. Amortization of Ansys intangible assets drags GAAP EPS guidance down to $3.84 to $4.08, which leaves a trailing P/E of 86. Backlog slipped slightly from the prior quarter, and Morgan Stanley (NYSE:MS) issued an earlier downgrade that warned of slowing growth. Export-control risk also remains unmeasured.
Strong Execution Meets a Stock That Keeps Round-Tripping
Margins of 41.6%, early debt paydown, and Ansys synergies running ahead of schedule all point to further upside. Repeated post-earnings drops and a still-heavy balance sheet support the bear case. Several key growth drivers, including royalties and joint products, are still in early adoption.
Wall Street Sees 16.6% Upside, but Shares Trail the Market
The consensus target of $569.78 implies 16.6% upside from current levels across 25 analysts. Price targets are one input and come with no guarantee.
- Strong Buy: 4
- Buy: 19
- Hold: 2
- Sell: 0
The stock gained 24.03% over the past month, compared with 0.61% for the S&P 500. Year to date, Synopsys is up just 3.99%, while the index has risen 13.63%. Its 52-week range runs from $362.55 to $539.48.
Fiscal Q4 Will Show Whether the Pattern Breaks
Synopsys trades at $488.47 heading into its next report.
The fiscal Q4 report is the next real test. Guidance calls for revenue of $2.53B to $2.58B and non-GAAP EPS of $4.10 to $4.16. A beat that holds for a full month, followed by a move above $539.48, would signal a break from the pattern.
Downside risks would build if Design IP stalls, EDA growth misses double digits, or export rules tighten. Each quarter, watch IP momentum, debt reduction, and signed royalty contracts.
The rally could continue. A fourth peak would carry its own risk, since the stock has fallen after each earnings report this year. Synopsys has earned attention, and the next test is whether it can hold a rally.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
